Abstract Alteration of the gut microbiota through diet and environmental contaminants may disturb the mammalian digestive system, leading to various diseases. Because most exposure to environmentally pyrethroid pesticides such as permethrin (PERM) occurs through the diet, the commensal gut microbiota is likely to be exposed to PERM. The study aimed at evaluating the effect of low-dose exposure to PERM in early life on the composition of fecal microbiota in rats. Over a 4-month follow-up period, fecal microbiota and short-chain fatty acids were measured in order to identify possible differences between PERM-treated rats and controls. Further in vitro antimicrobial experiments were conducted to establish the antibacterial activity of PERM against different strains to obtain Minimal Inhibitory Concentrations. The main finding focused on the reduced abundance of Bacteroides-P re v o t e l l a -P o r p h y ro m o n a s s p e c i e s , i n c r e a s e d
Introduction
Due to an increasing concern about adverse health consequences, organophosphate, carbamate, and organochlorine are being phased out leading to escalating use of an alternative class of pesticides, the pyrethroids. Pyrethroids are now the most commonly used pesticides for residential pest control, public health purposes, and for agriculture with biomonitoring studies confirming widespread exposure to one or more pyrethroids (Williams et al. 2008; Morgan 2012; Barr et al. 2010; Heudorf and Angerer 2001; Roberts et al. 2012) . One of the main routes of pyrethroid exposure involves dietary residues through food contamination (Barr et al. 2010; Heudorf and Angerer 2001) .
Although pyrethroid pesticides are often considered a Bsafer^choice because they are generally not as acutely toxic as organophosphates (Casida and Durkin 2013) , our studies on adult and adolescent rats indicated that oral long-term exposure to permethrin (PERM), one of the most representative pyrethroid compound, may not be benign (Nasuti et al. 2003; Gabbianelli et al. 2004; Nasuti et al. 2008) . In particular, Responsible editor: Philippe Garrigues Cinzia Nasuti and Maria Magdalena Coman contributed equally to this work.
oxidative damage to lymphocyte and erythrocyte was observed at doses of 150 mg/kg. However, a worst effect of PERM was observed when it was administered to rat pups during the suckling period from postnatal day (PND) 6 to PND 21 at doses of 34 mg/kg close to the No Observed Adverse Effects Levels (NOAEL) for PERM (25 mg/kg). Daily oral dose of PERM for 15 days induced dopamine and glutathione depletion together with lipid peroxidation in the basal ganglia of brain (Nasuti et al. 2007) .
In mammals, the postnatal period is characterized by the progressive colonization of the gut ecosystem by bacteria acquired during the delivery process, from the mother's skin and milk and other environmental and oral sources (Morelli 2008) . Subsequently, the presence of pesticide residues in food of young animals could induce variations in the gut microbiota that is essential for the development and maturation of gastrointestinal tract and enteric immune system, the maintenance of barrier function and the provision of essential nutrients. Furthermore, alterations in the colonization process predispose and increase the risk to disease later in life.
Given that weaning is a critical period for bacterial profile changes, we investigated, here, the impact of daily, oral exposure to low-dose PERM (34 mg/kg), from PND 6 to PND 21, on the fecal microbiota by using an in vivo model.
The changes over time in the populations of fecal microflora were examined at four different time points: PND 21 (weaning), PND 51 (adolescent age), PND 81 and PND 141 (adulthood). In parallel, control rats were gavaged daily with vehicle in order to establish possible differences between control and PERM-treated rats. In the same samples, we measured the fecal levels of short-chain fatty acids (SCFAs), which are the principle nutrient substrates of the intestinal epithelial cells and are themselves produced by commensal anaerobic bacteria via carbohydrate fermentation.
In vitro experiments were performed to establish the antibacterial activity of PERM against 16 different strains (Grampositives, Gram-negatives and yeasts) in order to obtain Minimal Inhibitory Concentrations (MICs). Moreover, we examined the effect of PERM on the relative levels of different bacterial groups present in the human fecal microbiota using a semi-continuous fermentor mimicking ileostomy fluid.
Materials and methods

In vitro studies
MICs of PERM
The in vitro experiments were performed using 16 different strains: Gram-positives, Gram-negatives and yeasts. The strains, their origins and their cultural and growth conditions were described in the Table 1. For each tested strains MIC was determined using a broth microdilution method with a 96-well microtiter plate (Clinical and Laboratory Standards Institute 2007) . One series of 2-fold dilutions of PERM in dimethyl sulfoxide and distilled water (DMSO:H 2 O ranging from 3.2 to 0.00625 mg/mL) for each microbial strain was prepared using the mean mentioned in the supplementary material. Each series was inoculated with 0.8 μL of each microbial strain (1.5 × 10 8 cells/ml). MIC determination, as the lowest concentration of PERM that inhibited the visible growth of the microorganisms after overnight/24/48 h of incubation at 37°C, was carried out evaluating the microbial growth in the wells using a stereomicroscope (GSZ2, Ascania, Germany).
Fermentation study
The medium used in this semi-continuous fermenter system was complex and designed to mimic either ileostomy fluid or ileal chime. The composition and the addition of fecal fluid and primary bile acids in the medium were those reported by Zampa et al. (2004) . Two experiments were performed (with three replicates for each): (i) a fermentation with semicontinuous culture with the addition of glucose in the medium (control test); (ii) a fermentation with semi-continuous culture with addition of 6 mL of PERM (1.28 mg in corn oil) in the medium each day. Each fermentation was run for 5 days.
A pool of freshly voided fecal samples from healthy volunteers with no history of gastrointestinal disease, both before and during the sampling period, and not undergoing antibiotic therapy one month prior to sampling, was used as inoculum. The procedures used in preparing the inoculum were reported in Zampa et al. (2004) .
The viable bacteria count (aerobes and anaerobes) was estimated by spreading tenfold dilutions of the original sample into selective agars (Silvi et al. 1996; Zampa et al. 2004 ). The bacteriological analysis was performed at different times of fermentation: immediately after inoculation (0 h), 24, 48, 72, and 96 h. The agar plates were spread in duplicate with 50 μL of diluted sample and then incubated in aerobic and anaerobic conditions at 37°C for 24-72 h.
In vivo studies
Materials
Technical grade (75: 25, trans: cis; 94 % purity) 3-phenoxybenzyl-(1R,S)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxyl-ate, PERM (NRDC 143) were generously donated by Dr. A. Stefanini of ACTIVA (Milan, Italy). Corn oil was obtained from Sigma (Milan, Italy).
Animals and treatment
Male and female Wistar rats aged about 90 days weighing 250-270 g were obtained from Charles River (Calco, LC, Italy). The animals were housed in plastic (Makrolon) cages (five rats/ cage) in a temperature controlled room (21 ± 5°C) and maintained on a standard GLP diet (4RF21, Mucedola S.r.l., Settimo Milanese, Milan, Italy) with water ad libitum. The composition of the standard diet was: raw proteins 167.4 g/kg, raw fats 20.0 g/kg, raw fibers 71.7 g/kg, raw ashes 63.3 g/kg.
The light/dark cycle was from 7 a.m. to 7 p.m. Male rat pups born in our laboratory from primiparous dams were used in the study. PERM-treated rats were treated daily by gavage with a PERM solution (34 mg/4 mL/kg body weight) from PND 6 to PND 21, whereas control rats were treated with the vehicle (corn oil 4 mL/kg body weight) on a similar schedule as previously described (Nasuti et al. 2013 ). The PERM solution was obtained by dissolving PERM in corn oil. Both control and PERM-treated groups were given free access to standard rat diet.
All procedures were carried out in accordance with the European guidelines (Directive 2010/63/EU) for the care and use of laboratory animals.
Experimental design
At the end of the treatment (PND 21) with PERM or vehicle, fecal pellets were freshly collected from six PERM-treated and six control rats; pellets were stored at −80°C until analysis of the microbiota by RT-PCR. Moreover, at PND 51, 81, and 141, fecal pellets were again collected and stored at −80°C until analysis to quantify selected bacterial strains and SCFAs.
For collection of feces, rats were held in metabolic cages. After 24 h, fecal output and food intake were measured.
Bacterial quantification by RT-PCR from fecal sample
A Real-Time quantitative PCR (QPCR) procedure was used for the quantification of the main bacterial groups of rats' intestinal microbiota by using specific primers, chosen from literature (Rinttila et al. 2004; Fang and Hedin 2003; Byun et al. 2004; Langendijk et al. 1995; Bartosch et al., 2004) as shown in the Table 2 . From each fecal sample the DNA was extracted using Stool DNA isolation kit (Norgen, Thorold, Canada). SYBR Green Real-Time PCR amplification was performed in triplicate using an iCycler iQ Real-Time Detection System (Stratagene) associated with MXP Software using the conditions reported in the supplementary material. For quantification of the above-mentioned target groups of bacteria, standard curves, previously generated for each of them as reported by Avella et al. (2010) , were used.
SCFA analysis
Six feces samples for each rat group (one feces sample for each rat) were analyzed by headspace solid-phase microextraction coupled to gas-chromatography equipped with flame ionization detection as previously reported (Fiorini et al. 2015) .
The results were expressed as μmol/g feces. The precision, as average of the relative standard deviation percentages, obtained analyzing independent replicates of each homogenized sample, was: 3.8 % (n = 36) for acetic acid, with a range of 0.3-13.2 %; 4.4 % (n = 36) for propionic acid, with a range of 0.6-13.8 %; 4.9 % (n = 36) for butyric acid, with a range of 0.9-13.0 %.
Statistical analysis
Data were presented as means ± standard deviation unless indicate otherwise. Bacterial data were expressed as mean of log 10 CFU/g. For the fecal analysis in the in vivo study, a two-way ANOVA with one factor within (time) and one factor between (treatment) was employed. When appropriate, post hoc analysis was carried out using the Newman-Keul test. Statistical significance was set at P < 0.05.
Results
MICs of PERM
The MIC results of PERM on the bacterial strains tested were showed in the Table 3 . PERM had inhibitory activity against both Gram-positive and Gram-negative bacteria.
Within the Gram-positives, Blautia producta DSM 2950 and Bifidobacterium spp. B1 were highly sensitive to PERM with MIC value of 0.4 μg/mL for both of them. On the contrary, either E. coli ATCC 13706 and Ps. aeruginosa DSM 1117, both Gram-negative, were less sensitive to PERM with values of 1.6 μg/mL for both of them. Also the two Candida In the range of pathogens more sensitive were the yeast strains as they required a low amount of this compound to be inhibited.
Effect of PERM on human fecal microflora in a semi-continuous fermentor
The bacterial counts on the fermentation samples related to all the studied bacterial groups and to all established time points did not show significant modulatory effect of PERM treatment within 96 h of fermentation in a semi-continuous fermentor mimicking ileotomy fluid when compared with fermentation samples treated with glucose (data not shown).
Effect of PERM on fecal microflora in rats
The standard curves had a very high efficiency (%), correlation coefficient (R 2 ) and slope obtained by plotting the threshold cycle values against the target DNA starting quantity. Using the formula E = [10(−1/slope)−1], the efficiencies for the individual assays were between 87.0 and 103.4 %. All of these parameters indicated a very good quality of the constructed standard curves and so a precise and accurate quantification of the samples. The results from the analysis of rat fecal samples were showed in Table 4 .
For Bacteroides-Prevotella-Porphyromonas spp., significant differences between control and PERM-treated groups were observed (F[1, 4] = 14.0, P = 0.019). Post hoc test showed that the PERM-treated group displayed a significant increase in these bacterial species at PND 21 (P = 0.043) and PND 51 (P = 0.021). Conversely, at PND 141, the levels of these species were significantly reduced in PERM-treated rats compared with controls (P = 0.019).
For Staphylococcus spp. and Bifidobacterium spp., results revealed no significant difference between control and PERM-treated groups (Staphylococcus spp.: For Lactobacillus spp., significant differences between control and PERM-treated groups were observed (F[1, 4] = 32.82, P = 0.004). In particular, post hoc test demonstrated that this bacterial species was significantly higher in PERM-treated group compared with that of controls at PND 21 (P = 0.001) and PND 51 (P = 0.022).
For Enterobacteriaceae, ANOVA revealed a significant treatment x time interaction (F[3, 12] = 4.23, P = 0.029), but not a significant effect of treatment (F[1, 4] = 4.54, P = 0.10). Post hoc analysis revealed that this bacterial family was significantly more abundant in PERM-treated rats than in controls at PND 51 (P = 0.01).
At all time points (PND 21, 51, 81, and 141), daily fecal output and food intake were measured in PERM-treated and control groups. No differences were reported between PERM- Data are expressed as mean of log 10 CFU/g ± standard deviation *P < 0.05 vs control group treated and control groups (daily fecal output: F[1, 10] = 0.003, P = 0.95; daily food intake: F[1, 10] = 0.43, P = 0.52).
Effect of PERM on fecal SCFA in rats
Acetic acid, propionic acid and butyric acid levels were reported in Fig. 1 . For acetic acid, two-way ANOVA revealed a significant treatment x time interaction (F[3, 12] = 4.74, P = 0.020), but not a significant effect of treatment (F[1,4] = 1.94, P > 0.05) as shown in Fig. 1a . Post hoc analysis revealed that this SCFA was significantly lower in PERM-treated rats than in controls at PND 21 (P = 0.017).
For propionic acid, two-way ANOVA revealed a significant treatment x time interaction (F[3,12] = 4.83, P = 0.019), but not a significant effect of treatment (F[1,4] = 0.004, P > 0.05) as shown in Fig. 1b . Post hoc analysis revealed that propionic acid was significantly higher in PERM-treated rats than in controls at PND 51 (P = 0.003).
For butyric acid, results revealed no significant treatment x time interaction (F[3,12] = 3.052, P = 0.069) and no significant difference between control and PERM-treated groups (F[1,4] = 0.35, P > 0.05) at all time points (Fig. 1c) .
Discussion
In previous studies, we demonstrated significant effects of permethrin especially on CNS when rat pups were orally exposed to doses (34 mg/kg) close to the NOAEL for PERM (25 mg/kg) (Carloni et al. 2012; Gabbianelli et al. 2014; Nasuti et al. 2007 Nasuti et al. , 2013 Nasuti et al. , 2014 . This pesticide belongs to the pyrethroid family and it is widely used in agriculture, in indoor environments such as households, warehouses, farm and public buildings for pest-control purposes. Consumption of fresh and cooked fruit and vegetables has been linked to higher levels of exposure, as confirmed by the quantification, in human urine, of the 3-phenoxybenzoic acid, the major metabolite of PERM (Barr, et al. 2010) . Although the digestive tract is the first organ to come in contact with food contaminants, little is known about the digestive impact of PERM. There are several studies on chlorpyrifos, a pesticide belonging to the organophosphate insecticide, demonstrating how low-dose exposure in perinatal age induces changes in gut microbiota and disrupts gut mucosal barrier (Joly et al. 2013; Joly Condette et al. 2015) , but no research on PERM impact on intestinal microbiota has yet been performed.
Since that the population is widely exposed to this pesticide, in this study we attempted to elucidate if early life exposure to PERM could affect gut microbiota monitoring the microbiota evolution over a 4-month follow-up period.
The main finding emerged from this study focused on the r e d u c e d a b u n d a n c e o f B a c t e ro i d e s -P re v o t e l l aPorphyromonas species in PERM-treated rats compared to controls at the end of the 4-month follow-up period. In this period of life, the present animal model develops motor disabilities similar of that observed in animal models of Parkinson's disease (paper under submission). The decrease of Prevotella family is associated with dysbiosis of the fecal microbiota in patients with Parkinson's disease (Scheperjans et al. 2015) .
Bacteroides species are responsible to produce higher levels of SCFA whose protective role against gut Fig. 1 Quantification of a acetic, b propionic, and c butyric acids, expressed as μmol/g feces, in control and PERM-treated rats over a 4-month follow-up period. Bars represent means ± standard deviation inflammation has been well proven (Scheppach et al. 2004) . Among them, butyrate plays a particular role for maintaining the intestinal barrier, as shown in inflammatory bowel disease, in which deficit in butyrate causes tight junction lesions and finally impaired intestinal permeability. However, in the present study, no decrease in fecal butyrate was observed in PERM-treated rats versus controls across all times of observation. On the contrary, differences between PERM-treated and control groups were observed for acetic and propionic acids. At the end of the last treatment with PERM (PND 21), acetic acid was decreased in feces of PERM-treated group compared to control. At PND 51, propionic acid was increased in PERM-treated rats. Considering that both groups were fed with the same laboratory diet and no difference was observed in daily food intake and fecal output, the results let us to speculate that PERM treatment could be responsible for the disruption of microbiota composition followed by changes on the end products of fermentation. Particularly, nondigestible carbohydrates are fermented in the proximal colon by primary fermenters like Bacteroides that produce CO 2 and lactate. The first is converted to acetic acid by acetogens via the WoodLjungdahl pathway, whereas the second is reduced to propionic acid by other members of the microbial community through the acrylate pathway (Den Besten et al. 2013) . Here, in the PERM-treated rats, the bacterial pathway related to acetic acid seems to be partially suppressed whereas the pathway related to propionic acid production appears to dominate over those observed in the control rats. Although diet is a major determinant of gut microbiota, the ingestion of exogenous compound like permethrin may exert a strong influence on the colonic milieu and on the microbial population which in turn affects SCFA production.
Regarding Enterobacteriaceae, which contains most of the opportunistic pathogens, the results showed a trend to a slight increment in their abundance in PERM-treated rats compared to controls at PND 21 followed by a significant increase at PND 51 the second end point. The increase of this bacteria family, especially the pathogenic Escherichia coli strain, is associated with dysbiosis of the fecal microbiota in patients with Parkinson's disease (Scheperjans et al. 2015) . Hence, the oral treatment with PERM appears to have changed the normal microenvironment that is suitable for beneficial populations, thereby allowing opportunistic pathogens like Enterobacteriaceae to invade and colonize. However, at PND 81 and PND 141, the Enterobacteriaceae abundance in PERM-treated rats were similar to controls; most probably compensatory mechanisms intervene to mitigate the gut microbiota unbalance observed at the previous time points.
Indeed, the increase of Lactobacillus observed in PERM-treated rats, at PND 21 and PND 51, could represent a compensatory response that, most probably, had prevented the pathogenic Enterobacteriaceae overgrowth at PND 81 and PND 141. Moreover, the findings of in vitro studies ruled out the possibility that PERM in the gut had a trophic effect on lactobacillus because the latter was very sensitive to PERM as shown by a MIC value of 0.8 μg/mL.
In the fermentation experiment performed on human fecal microflora, PERM did not have modulatory effects on all bacteria species analyzed. However, Kaufman (1977) found that PERM residues had a short-term inhibitory effect on the functional diversity of soil microbes because microbes can use low-dose PERM as a source of phosphorus or carbon. In the present study, PERM may have a similar impact on bacterial strains. Further, Wagenet (1985) showed that the addition of nutrients to soil may increase the degradation of PERM. Accordingly, we suggest that the addition of low-dose PERM, in these experimental conditions, could be used as an energy source providing a strong benefit to the bacteria species, in fact we observed the same effect when the fermentation was done with addition of glucose.
In conclusion, our data demonstrated that low-dose postnatal exposure to PERM affects negatively the gut microbiota in rats with a decrease in numbers of some strains such as Prevotella that might have a negative impact on gut health. Further studies are warranted to detect the impact of PERM on intestinal mucosa and to include other bacterial families that may increase accuracy, and the potential of fecal microbiome analysis as a biomarker able to detect diseases.
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